The PROOF Centre has granted HTG Molecular Diagnostics exclusive rights to commercialize PROOF Centre-developed gene expression blood tests for the prognosis of patients with Chronic Obstructive Pulmonary Disease (COPD) who will experience frequent exacerbations (“lung attacks”).
The PROOF Centre – …
A hearty congratulations to our trainee, Casey Shannon, who won one of the two awards given out for the best oral presentation at the 16th Annual Transplant Research Day that took place on December 3, 2012. In his presentation …
The latest publication by the PROOF Centre indicates that proteo-genomic biomarker ensemble classifiers show promise in the diagnosis of acute rejection in kidney transplant recipients, and can improve classification performance beyond that of individual genomic or proteomic classifiers alone. Click …
Seven years ago, Andrea Marrie unexpectedly became a heart transplant candidate when she was found teetering at the precipice of end stage heart failure. A healthy and vivacious young woman who was just twenty-two years old, nobody anticipated Andrea to …
IO Informatics this week launched a new business arm, dubbed IO Healthcare, that will focus on helping customers in the personalized medicine market use clinical information to enhance their research and development activities. Read more here.…